课题基金 / 基金详情

The role of Interleukin-21 in the pathogenesis of autoimmune diabetes

The role of Interleukin-21 in the pathogenesis of autoimmune diabetes
Interleukin-21在自身免疫性糖尿病发病机制中的作用
批准号:
nhmrc : 358307
负责人:
A/Pr Cecile King
金额:
$34.61万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2005
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2005-01-01 至 2007-12-31

项目摘要

项目成果

A/Pr Cecile King的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
T cells are a component of our blood (white blood cells) and a major component of the body's defense system against infection, known as immunity. Without T cells, we would fail to resist infection by foreign agents, such as viruses, bacteria and fungi. Autoimmune (type 1) diabetes is a disease in which T cells attack our own pancreatic islet self tissues as if they were foreign. T cells that react against the islets of the pancreas cause destruction of the insulin producing beta cells so that the pancreas can no longer make insulin. Diabetes is a life-threatening disease because insulin is a hormone that enables people to get energy from food. Type 1 diabetes is usually diagnosed in childhood and insulin must be administered daily by injection or through a pump in order to survive. Unfortunately, taking insulin doesn t cure diabetes and people continue to suffer from an extensive list of complications affecting most vital organs. Interleukin-21 (IL-21) is a soluble protein that is produced by cells enabling them to communicate with other cells. IL-21 helps cells to produce factors that cause inflammation and assist in clearance of viruses and bacteria from the body. However, our studies show that IL-21 is a major factor in the development of the T cells that destroy beta cells and cause diabetes. Our studies show that IL-21 is over-expressed in an important murine model of spontaneous type-1 diabetes. We have isolated the T cells that cause diabetes and show that they are distinguished from other T cells by very high levels of the receptor for IL-21. This project focuses on the IL-21-responsive T cells that cause diabetes and aims to determine the mechanisms by which the cytokine IL-21 causes destructive immune responses and ways to modulate its production. This project applies basic science to the important public health issue of type 1 diabetes for the development of therapeutic intervention strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of Action of Interleukin-2 Superkines
  • 批准号:
    nhmrc : GNT1148051
  • 项目类别:
    Project Grants
  • 资助金额:
    $72.56万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Cecile King
  • 依托单位:
Mechanisms of Action of Interleukin-2 Superkines
  • 批准号:
    nhmrc : 1148051
  • 项目类别:
    Project Grants
  • 资助金额:
    $49.06万
  • 财政年份:
    2018
  • 负责人:
    A/Pr Cecile King
  • 依托单位:
Interleukin signalling in CD4+ T cell differentiation
  • 批准号:
    nhmrc : 1087408
  • 项目类别:
    Project Grants
  • 资助金额:
    $44.27万
  • 财政年份:
    2015
  • 负责人:
    A/Pr Cecile King
  • 依托单位:
Interleukin signalling in CD4+ T cell differentiation
  • 批准号:
    nhmrc : GNT1087408
  • 项目类别:
    Project Grants
  • 资助金额:
    $64.31万
  • 财政年份:
    2015
  • 负责人:
    A/Pr Cecile King
  • 依托单位:
国内基金
海外基金
Interleukin1β炎症通路通过促进精胺代谢介 导抗癫痫药多药耐药的作用及机制研究
  • 批准号:
    Q24H310010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    汤莹莹
  • 依托单位:
凝血酶介导的 Interleukin-33 活化在二型免疫反应中功能机制研究
白介素-1受体相关激酶(Interleukin-1 receptor associated kinase,IRAK)-M调节哮喘气道炎症异质性和气道重塑以及相关机制的研究
Interleukin-1α和 Interleukin-1β调节大鼠Leydig干细胞增殖和分化的机制研究
  • 批准号:
    LY19H040005
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2018
  • 负责人:
    曹淑彦
  • 依托单位: